|
HS Code |
574379 |
As an accredited 4-Bromo-3-Iodobenzotrifluoride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-3-Iodobenzotrifluoride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Ask any experienced organic chemist or chemical researcher, and you’ll hear a familiar theme: new molecular structures can lead to new insights and capabilities. 4-Bromo-3-Iodobenzotrifluoride stands out as a versatile intermediate that supports vital innovations across pharmaceutical, agrochemical, and materials research. This compound, recognized by CAS number 175277-52-6 and the formula C7H3BrF3I, offers chemists a balance of reactivity and stability that unlocks options in multi-step syntheses. Distinct from other halogenated benzotrifluorides, this molecule brings a unique mix of functional sites, making selective transformations more accessible and simplifying some of the toughest challenges in constructing complex molecular frameworks.
Anyone who’s worked with poly-halogenated aromatics knows the value of strategic functional group placement. With both bromine and iodine attached to the aromatic ring, 4-Bromo-3-Iodobenzotrifluoride offers a dual-handle reactivity that few other trifluoromethylated benzenes provide. As someone who has tried coaxing performance out of similar scaffolds, I can vouch for the utility added by having both sites available for sequential Suzuki, Sonogashira, or Buchwald–Hartwig coupling reactions. The steric and electronic effects of the trifluoromethyl group influence morphological outcomes, affecting the rate and selectivity of many transformations. Researchers have published work showing stronger regioselectivity and improved yields in metal-catalyzed couplings, all thanks to the unique arrangement of bromine at the 4-position and iodine at the 3-position of the aromatic core. In my experience, this fine-tuned reactivity shortens synthetic routes and boosts reliability when planning tricky sequences.
The practical details matter when you're running a reaction and depending on a clean conversion. 4-Bromo-3-Iodobenzotrifluoride typically arrives as a dense, colorless to pale yellow liquid, though batches might sometimes sport a faint haze that clears up after careful handling. Analytical checks—NMR, GC-MS, and HPLC—consistently show high purity exceeding 98%. Moisture and oxygen sensitivity remain low, so storage isn’t a constant worry, but keeping bottles in a cool, dry spot makes for an easy habit. The molecular weight (368.91 g/mol) doesn’t just serve as a dry fact; it sets the expectations when scaling up from milligram to multigram quantities. Handling it brings no more complexity than similar reagents, and I find it less prone to stubborn residues or vapor loss compared to lighter trifluoromethyl halides. This predictability encourages confidence in both bench science and industrial settings, where wasted time and uncertain yield cut straight into progress.
Synthesis isn’t just about piecing together atoms—it’s about transforming ideas into tangible outcomes. In academic labs and industrial R&D centers, 4-Bromo-3-Iodobenzotrifluoride helps bridge imagination and practicality. Its main appeal springs from cross-coupling chemistry: the presence of both aryl bromide and aryl iodide in one skeleton offers staged selectivity for forming carbon-carbon or carbon-heteroatom bonds. My own projects have benefitted from this dual functionality, especially in iterative coupling steps where the milder activation of aryl iodide opens the first transformation, leaving the bromide for subsequent, more robust conditions. It’s routine in the development of kinase inhibitors or aryl-substituted fluorinated fragments used in advanced drug frameworks. These applications often require orthogonal reactivity to stitch together diverse architectures—a task where this compound shines compared to more basic monochloro or monobromo alternatives.
Digging into the literature, 4-Bromo-3-Iodobenzotrifluoride comes up repeatedly as a key starting material for synthesizing fluorinated biphenyls, diaryl ethers, and heterocyclic fragments that show up in preclinical drug candidates. A simple alkylation or arylation at the iodine handle, followed by a further coupling at the bromine, can rapidly diversify potential leads. In agrochemicals, researchers have built fluorinated herbicide and pesticide cores with this sort of modular strategy, finding improvements in bioavailability and environmental persistence that are tied to the trifluoromethyl group. Out in the world of organic electronics, the strong electron-withdrawing effect of CF3, paired with carefully chosen substituents, has led to small molecules and polymers used as hole-transport layers and tuning agents for OLEDs and solar cells. Real-world application depends on being able to customize molecules in ways dictated by these industries’ needs—a flexibility that this dual-halogen reagent puts front and center.
Draw comparisons to more commonplace halogenated trifluorobenzenes, and several strengths come into focus. Take 4-Bromo-3-Iodotoluene, sometimes proposed as a similar intermediate: swap the methyl for a trifluoromethyl, and you see differences in chemical stability, electron density, and reactivity under Pd-catalysis. The CF3 group lowers the electron density on the ring, making nucleophilic aromatic substitution less competitive and improving yields in metal-catalyzed coupling routes. With 4-Bromo-3-Iodobenzotrifluoride, aryl–aryl bond formation becomes more controlled, unwanted side reactions drop, and isolation of clean products gets easier. Having two separate halogens means routes can be tailored for orthogonality: the iodine reacts fast and gently, the bromine adds another step when conditions call for it. In side-by-side experiments, this approach usually requires fewer protecting groups, offers higher yields, and compresses timelines. Anyone navigating tight deadlines can appreciate skipping redundant workups or tedious purifications.
As chemistry leans into greener processes and regulatory scrutiny grows sharper, the sustainability of a compound’s lifecycle matters more than ever. I’ve watched as sourcing reliable, well-documented intermediates becomes a sticking point for teams pursuing both commercial and academic goals. 4-Bromo-3-Iodobenzotrifluoride sits in a sweet spot: it doesn’t carry some of the toxic baggage of poly-chlorinated aromatics or persistent byproducts. Suppliers increasingly back up purity and provenance with analytical verification, performance histories, and traceability information. While pricing still depends on lot size and global market shifts affecting iodine availability, the compound’s benefits in reducing synthesis steps can make up for initial outlays. Efficient use means fewer wasted reagents, lower energy costs, and smaller productivity gaps when scaling up from gram to kilo scales.
Working with halogenated aromatics always brings real-world handling concerns. I’ve seen a few cases where complacency led to minor irritations, though nothing outside the usual for this class of chemicals. Following common lab protocols—working in a fume hood, wearing gloves, and minimizing open container times—has worked well over years of direct use. On the waste front, disposal regulations for compounds harboring both bromine and iodine call for careful containment and neutralization, especially in scale-up manufacturing or pilot plant runs. Larger shipments still navigate customs and regulatory bodies that flag halogenated organics for extra scrutiny. Open communication with vendors about documentation and compliance requirements can head off supply chain disruptions.
Every project I’ve seen that shifted from a mix-and-match cocktail of monohalogenated trifluoromethyl benzenes to this dual-halogen approach pointed to measurable gains in efficiency. In one memorable case, a medicinal chemistry team cut two weeks from their synthesis by shaving away a protection–deprotection sequence, all because the intermediate matched their stepwise reactivity needs. Reliability counts for a lot when you’re moving from milligram to gram scales—and each time, this compound maintained consistent yields, predictable product profiles, and fewer purification headaches. Labs pushing the boundaries of fluorinated small molecules keep reporting similar observations: more headway made in less time, fewer surprises, and easier troubleshooting when something did go astray.
A decade ago, it wasn’t unusual to lean on basic bromobenzenes or monochloro aromatics for routine transformations. The birth of new catalytic systems, plus the demand for intricate functional molecules, has moved the goalposts. Now, access to highly selective intermediates like 4-Bromo-3-Iodobenzotrifluoride supports the construction of conformationally rigid, highly functionalized structures that underpin modern drugs, crop protectants, and high-performance materials. The pharmaceutical sector in particular has tracked the growing importance of CF3-bearing scaffolds in delivering oral bioavailability, metabolic stability, and unique binding profiles in active ingredients. Every step forward in these fields owes much to the reliability and adaptability of the building blocks at the chemist’s disposal.
Look over the last ten years of published research and patent filings, and the frequency with which this intermediate shows up speaks volumes. Academic groups have used it for model studies of cross-coupling mechanisms, and development chemists have relied on it for scalable routes to proprietary molecules. Its traceable structure brings analytical clarity, helping teams map MS and NMR data directly to expected outcomes and avoid mismatches. In the hands of skilled practitioners, the reactivity package offered by the two halogens shortens time spent on redundancy and error correction, bringing projects to completion on tighter timelines. Even as new trifunctional and more exotic building blocks emerge, the practical performance and reliability of this molecule keep it relevant.
Those tackling demanding synthetic sequences often face bottlenecks—either something won’t react, selectivity falls off, or cleanup turns into a nightmare. Here’s where 4-Bromo-3-Iodobenzotrifluoride stands out. Its well-behaved reaction profile helps drive transformations to completion where other reagents might quit or produce messy mixtures. In my experience, staged coupling makes synthesis more predictable and less labor-intensive, especially in academic settings where time and budgets stretch thin. For industrial chemists, consistency across batches and process scale reduces the risk of delays and compliance headaches. Supplier relationships built on transparency enable smoother workflows—each participant knows exactly what combination of analytical, safety, and logistical support to expect. As analytical techniques get sharper, the confidence in what’s being weighed into flasks or added to reactors only grows stronger.
Modern synthetic chemistry can only advance as fast as the quality of its raw materials permits. I’ve seen firsthand that reliable supply and candid communication about performance and risks matter as much as price. The shift toward open data and supplier openness about analytical profiles directly supports the core scientific value of reproducibility. Teams making regulatory filings for new drugs or materials depend on consistent, verified sources. In every case, the intermediate serves not just as a structural fragment, but as a touchstone for teamwork, planning, and scientific trust. Skimping here rarely pays off in the long run.
Progress in high-throughput screening, automated synthesis, and green chemistry will keep pushing for intermediates that deliver flexibly and with minimized waste. 4-Bromo-3-Iodobenzotrifluoride is well-suited for the direction these trends are moving. With laboratories committed to data-driven optimization, even small improvements in yield, selectivity, or purification logistics translate into better outcomes. Experts are already exploring further derivatization possibilities, looking at how tweaks to halogen position and substituent choices open doors to entirely new compound classes. As collaborative research across institutions grows, compounds with track records of reliability and tunable reactivity—like this one—will take central roles in major innovation efforts.
From firsthand use and careful review of the current literature, 4-Bromo-3-Iodobenzotrifluoride continues to distinguish itself as a workhorse in advanced synthesis labs. The balance of reactivity, selectivity, and practicality answers the needs of chemists in both small-batch research and larger commercial pursuits. Compared to simpler halogenated intermediates, it carries the benefits of stepwise functionalization and reduced waste, all supported by a well-understood safety and handling profile. As the demands on chemical synthesis continue to evolve, intermediates like this—backed by transparency, analytical rigor, and proven versatility—look set to maintain a central role in everything from early discovery to late-stage manufacturing. Each success story with this compound is a testament to the years of accumulated knowledge, incremental innovation, and shared progress across the fields of medicine, agriculture, and materials science. The next generation of molecular breakthroughs will owe much to the careful choice of such foundational building blocks.